News

ALL RIGHT, LET’S START THIS OVER, SHALL WE? IN THIS MORNING’S WOMAN’S DOCTOR, CERVICAL CANCER IS ON THE RISE IN MILLENNIAL WOMEN. A JAMA STUDY SHOWED THE DISEASE HAS RISEN BY 2.5% PER YEAR ...
Cervical cancer remains a significant global health concern for women, with hundreds of thousands of new cases and deaths reported annually. While HPV is a primary cause, early detection and HPV ...
The diagnoses and treatment of noncommunicable diseases such as diabetes, high blood pressure, cervical cancer, depression and anxiety will also become harder. We break down five ways in which HIV ...
AMID the noise generated by the now-concluded midterm elections, one vital public health campaign has been largely overshadowed by it: May as Cervical Cancer Awareness Month. Established through ...
MSD’s checkpoint inhibitor Keytruda has been cleared by the FDA for use in newly diagnosed cervical cancer patients with less severe disease, becoming the first anti-PD-1/PD-L1 immunotherapy for ...
The campaign will deploy a government-provided cancer screening van across the city to conduct on-site tests for oral, breast, and cervical cancers. As part of the ongoing National NCD Screening ...
Cervical cancer is preventable, but kills thousands each year — in part because women aren't regularly screened for it. A new test allows people to test themselves at home and mail in the ...
Tivdak is a first-in-class therapy that combines an antibody target at tissue factor – a protein expressed on cervical cancer cells – with a cell-killing drug called monomethyl auristatin E.
WASHINGTON (TNND) — The FDA approved its first-ever at-home test for cervical cancer called Teal Wand. It detects HPV. Dr. Ryan Cole, a senior fellow of pathology at the Independent Medical ...
Human Papillomavirus (HPV) - a major cause of cervical cancer - has been foundin an average of 4.27% of women in Bangladesh in a study over the past five years. This was revealed at a national event ...
Survival rates were similar at 3 years, 5 years, 7 years, and 10 years. Patients with low-risk, early-stage cervical cancer have similar long-term survival outcomes whether they undergo simple ...